Surpass Inc is categorized under Commercial Medical Research in Osceola, WI and active since 2006.
Surpass Inc was established in 2006, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Liann Johnson, President at the company’s single location by writing to 803 Prospect Avenue, Osceola, Wisconsin WI 54020 or by phoning (715) 294-4371. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Surpass Inc |
| Contact Person: | Liann Johnson, President |
| Address: | 803 Prospect Avenue, Osceola, Wisconsin 54020 |
| Phone Number: | (715) 294-4371 |
| Website Address: | surpassinc.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6215110 |
| Share This Business: |
Surpass Inc was started in 2006 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Liann Johnson, President for inquiries that concern Surpass Inc by calling the company number (715) 294-4371, as your correspondence is most welcome. Additionally, the physical location of the single location of Surpass Inc can be found at the coordinates 45.32149,-92.68396 as well as the street address 803 Prospect Avenue in Osceola, Wisconsin 54020.
For its online presence, you may visit Surpass Inc’s website at surpassinc.com and engage with its social media outlets through on Twitter and on Facebook.